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Background: The epithelial Ca2 channel TRPV5 facilitates Ca2 reabsorption in the kidney and is regulated by sialidase
and the hormone klotho.
Results: Sialidase stimulates TRPV5 plasma membrane stabilization in a lipid raft-dependent manner, while klotho increased
cell surface expression of the channel via its N-glycan.
Conclusion: Klotho and sialidase regulate TRPV5 membrane stabilization in a different manner.
Significance: Understanding the regulation of TRPV5 is crucial to treat patients with Ca2-related disorders.
The transient receptor potential vanilloid type 5 (TRPV5)
Ca2 channel facilitates transcellular Ca2 transport in the dis-
tal convoluted tubule (DCT) of the kidney. The channel is gly-
cosylated with a complex type N-glycan and it has been postu-
lated that hydrolysis of the terminal sialic acid(s) stimulate
TRPV5 activity. The present study delineates the role of the
N-glycan in TRPV5 activity using biochemical assays in
Human Embryonic Kidney 293 cells expressing TRPV5, iso-
electric focusing and total internal reflection fluorescent
microscopy. The anti-aging hormone klotho and other glyco-
sidases stimulate TRPV5-dependent Ca2 uptake. Klotho
was found to increase the plasma membrane stability of
TRPV5, via the TRPV5 N-glycan. Sialidase mimicked this
stimulatory action. However, this effect was independent of the
N-glycosylation state of TRPV5, since the N-glycosylation
mutant (TRPV5N358Q) was activated to the same extent. We
showed that the increased TRPV5 activity after sialidase treat-
ment is caused by inhibition of lipid raft-mediated internaliza-
tion. In addition, sialidase modified theN-glycan of transferrin,
a model glycoprotein, differently from klotho. Previous studies
showed that after klotho treatment, galectin-1 binds the TRPV5
N-glycan and thereby increasesTRPV5activity.However, galec-
tin-3, but not galectin-1, was expressed in the DCT. Further-
more, an increase in TRPV5-mediated Ca2 uptake was
detected after galectin-3 treatment. In conclusion, two distinct
TRPV5 stimulatory mechanisms were demonstrated; a klotho-
mediated effect that is dependent on theN-glycan ofTRPV5and
a sialidase-mediated stimulation that is lipid raft-dependent
and independent of the N-glycan of TRPV5.
Calcium (Ca2) plays a crucial role in multiple physiological
processes such as muscle contraction, neuronal excitability,
enzymatic activity, bone formation, cell membrane formation,
and exocytosis. It is of physiological importance to tightly reg-
ulate intra- and extracellular Ca2 levels. To this end, the Ca2
balance ismaintained by the bone, kidney, duodenumandpara-
thyroid glands (1). Secretion of parathyroid hormone (PTH)2
by the parathyroid glands results in increased Ca2 re(ab)sorp-
tion from both bone and kidney. The rate-limiting step in renal
active Ca2 reabsorption is the uptake by the transient receptor
potential vanilloid type 5 (TRPV5) channel, which is apically
expressed in the distal convoluted tubule (DCT) of the kidney
(2–5). The channel is responsible for 8% of the total Ca2 reab-
sorption (6). TRPV5 is a tetramericmembrane protein contain-
ing 6 transmembrane segments, with a cytosolic amino and
carboxyl terminus and an extracellular N-glycan at asparagine
358. TheN-glycan is an important post-translational regulatory
site, which can affect the plasma membrane retention of the
channel (7).
Previous studies have shown that intracellular N-glycans
contribute to signaling processes, dimer formation, membrane
trafficking and polarized sorting of glycoproteins to the apical
surface of epithelial cells (8, 9). Extracellular N-glycans of
plasma membrane glycoproteins are involved in signaling pro-
cesses, apoptosis and cell-cell contacts. The composition of
these glycans and the properties of the glycoproteins can be
influenced by the activity of extracellular glycosidases (10–12).
For example, previous studies demonstrated that sialidase, a
glycosidase, affects caveolar-mediated endocytosis by interact-
ing with glycolipids in the plasma membrane (13). Trafficking
of TRPV5 is crucial for controlling its abundance at the plasma
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A protein that modifies the extracellularN-glycan of TRPV5
is the type-1 glycoprotein, klotho (7, 14, 15). Klotho is a glyco-
sidase that participates in the degradation of glycans and
thereby affects different glycoproteins (7, 15–17). Other glycosi-
dases, such as -glucuronidase and sialidase, mimic the plasma
membrane stabilization effect of klotho on TRPV5 by modifying
itsN-glycan. It was hypothesized that klotho has -glucuronidase
activity, because this enzyme has homology with -glucuroni-
dase and is able to hydrolyze glucuronic acids (16). Treatment
of Human Embryonic Kidney 293 cells (HEK293) expressing
TRPV5 with -glucuronidase also increased the Ca2 uptake
through TRPV5 (7). However, Tohyama et al. found that the
-glucuronidase activity of klotho is26 times lower than that
of -glucuronidase (16). In addition, two highly conserved glu-
tamate residues, essential for the enzymatic activity of -glucu-
ronidase, are not conserved in klotho. Furthermore, glucuronic
acids are uncommon moieties in N-glycans of membrane pro-
teins such as TRPV5. Cha et al. proposed that klotho operates
instead as an exo-sialidase, specifically breaking the -2,6-
linked bonds of the negatively charged sialic acids (14). They
postulated that in Chinese Hamster Ovary (CHO) cells, cleav-
age of sialic acids by klotho exposes the underlying disaccharide
galactose--(1–4)-N-acetylglucosamine, followed by binding
of galectins, a group of carbohydrate-binding proteins with a
high affinity for the exposed galactose-N-acetylglucosamine
disaccharides.
One of the galectin familymembers is galectin-1, a polyvalent
protein expressed in various tissues and with a wide range of
biological activities. It was suggested that galectin-1 forms a
stable complex with TRPV5, resulting in a stimulatory effect on
Ca2 reabsorption by TRPV5 retention at the cell surface (14).
Galectin-1 is present in both extra- and intracellular compart-
ments, where it binds to carbohydrate and non-carbohydrate
molecules, respectively (18). Galectin-1 is found in human
tubular epithelial cells and in extensive amounts in the porcine
kidney (19).
The aim of the present study was to investigate the underly-
ing molecular mechanism of the klotho-mediated TRPV5 reg-
ulation and the involvement of galectins. To this end, we delin-
eated the action of different glycosidases, viz. klotho and
sialidase. Total Internal Reflection Fluorescent Microscopy
(TIRF-M) combined with a photo-switchable fluorescent pro-
tein enabled us to study the dynamics of TRPV5 proteins on the
plasmamembrane inHEK293 cells. Finally, isoelectric focusing
(IEF), allowed the detection of klotho-mediated sialic acid
hydrolysis on a model glycoprotein, transferrin.
EXPERIMENTAL PROCEDURES
DNA Constructs—The pCINeo/IRES-GFP plasmid encod-
ing TRPV5 was generated as described previously (20).
TRPV5N358Q was obtained by in vitro mutagenesis of TRPV5-
pCINeo/IRES-GFP cDNA according to the manufacturer’s
instructions (Stratagene, La Jolla, CA). The pcDendra-2 (Evro-
gen,Moscow, Russia) was amplified by PCR and ligated into the
pCINeo/IRES-HA TRPV5 construct using the NheI and EcoNI
(New England Biolabs, Ipswich, MA) restriction sites. All con-
structs were verified by DNA sequence analysis.
Immunoblotting and Protein Concentration Determination—
TRPV5 protein expression was determined by 8% (w/v) SDS-
PAGE and Western blotting using anti-TRPV5 (1:4.000, (21))
with peroxidase-labeled goat anti-mouse IgG (1:10.000, Sigma-
Aldrich) antibodies. Protein concentrationwasmeasured using
the BCA protein assay kit (Thermo Scientific, Rockford, IL),
according to the manufacturer’s manual.
Electrophysiology—Whole-cell currents were measured with
an EPC-10 (HEKA electronic) amplifier using Patchmaster
V2.20 software. The borosilicate glass electrode resistance was
between 2.5 and 4 M. The ramp protocol for measuring the
current-voltage (I/V) relationship of Na consisted of linear
voltage ramps from100 to100 mV within 450 ms repeated
every 5 s. The step protocol for measuring the Ca2 current
consisted of a 10 s long voltage-step applied from70 to100
mV. Current traces were sampled at 0.5 ms for the ramp and 2
ms for step protocol. Reported current densities were calcu-
lated from the current at 80 mV during the ramp protocol.
The standard extracellular solution contained 150 mM NaCl, 6
mM CsCl, 10 mM HEPES (pH 7.4 adjusted with NaOH), 50 M
EDTA, and 10 mM glucose. For Ca2 current measurements
NaClwas replacedwith equimolarNMDG-Cl and 10mMCaCl2
was added. Osmotic differences were adjusted by adding a
respective amount of mannitol. The internal (pipette) solution
contained 20 mM CsCl, 100 mM Cs-aspartate, 1 mM MgCl2, 10
mM BAPTA, 4 mM Na2ATP, and 10 mM HEPES (pH 7.2
adjusted with CsOH). Data were analyzed using Igor-pro soft-
ware (WaveMetrics, Oswego, OR).
45Ca2 Uptake Assay—HEK293 cells were transiently trans-
fected with TRPV5 in pCINeo/IRES-GFP, TRPV5N358Q in
pCINeo/IRES-GFP or the empty pCINeo/IRES-GFP vector
(mock). One day after transfection, cells were reseeded on poly-
L-lysine-coated (0.1 mg/ml) culture dishes and incubated with
recombinant klotho (2 g/ml, R&D systems, Minneapolis,
MN), sialidase from Vibrio cholerae (27 mU/ml, Sigma-Al-
drich), -glucuronidase from bovine liver (310 units/ml, Sig-
ma-Aldrich), endoF (1 kU/ml, New England), a combination of
glycosidases, or human galectin-3 (0.67 g/ml, Prospec, Ness
Ziona, Israel) for 16 h at 37 °C. Radioactive 45Ca2-uptake in
TRPV5-transfected HEK293 cells was determined as described
previously (22).
Plasma Membrane Biotinylation and TRPV5 Cell Surface
Turnover—HEK293 cells were transiently transfected with
TRPV5 in pCINeo/IRES-GFP, TRPV5N358Q in pCINeo/IRES-
GFP or the empty pCINeo/IRES-GFP vector (mock). One day
after transfection, cells were reseeded on poly-L-lysine-coated
(0.1 mg/ml) culture dishes and incubated with recombinant
klotho (2 g/ml, R&D systems), sialidase from V. cholerae (27
mU/ml, Sigma-Aldrich), -glucuronidase from bovine liver
(310 units/ml, Sigma-Aldrich), or endoF (1 kU/ml, New Eng-
land Biolabs) for 16 h at 37 °C. Subsequently, cells were biotin-
ylated as described previously (7). For time point 0 h cells were
collected from the plates and disrupted in 1 ml of lysis buffer
[1% (v/v) Nonidet P-40, 150mMNaCl, 5mM EDTA, 50mMTris
(pH7.5 adjustedwithHCl), 1mMPMSF, 10g/ml leupeptin, 10
g/ml pepstatin, 5g/ml proteinaseA] immediately after bioti-
nylation. For the other investigated time points, cells were cul-
tured in the absence of glycosidases for an additional 1 or 3 h at
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37 °C, subsequently washed with ice-cold PBS and homoge-
nized in 1 ml of lysis buffer. TRPV5 protein expression at the
cell surface and in total cell lysate was investigated as described
previously (7).
Total Internal Reflection Microscopy (TIRF-M)—HEK293
cells were transiently transfected with pcDNA3-Dendra2-
HA-TRPV5andpcDNA3-Dendra2-HA-TRPV5N358Q24hbefore
the experiment. TIRF-M cells were harvested in 15 ml tubes and
resuspended in conditioned medium containing recombinant
klotho (2g/ml, R&D systems) or sialidase fromV. cholerae (27
mU/ml, Sigma-Aldrich). The tubes were rotated for 1.5 h at
37 °C to increase the effective reactive surface of the cells. Cells
were reseeded on small Petri dishes (WilCo, Amsterdam, The
Netherlands) coatedwith 50g/ml fibronectin and cultured for
2–7 h before subjected to TIRF-M. Dishes were washed and
placed in a custom-made chamber with Krebs buffer (135 mM
NaCl, 5 mM KCl, 1.5 mM MgCl2, 1.5 mM CaCl2, 20 mM HEPES
(pH 7.4 with NaOH), 10 mM D-glucose,) and imaged at room
temperature. The Olympus Fluoview FV1000-IX81 confocal
microscope, with fully integrated TIRF module, and equipped
with a PLAPON60xO/TIRFM-SP-PlanApochromatic objec-
tive 60x oil, NA 1.45 and WD  0,10 mm lens was used to
measure fluorescence. Photoconversion of Dendra2 was car-
ried out using a 405 nm laser for 2 s. TRPV5 membrane traf-
ficking was followed for about 36 min and every 3 min images
were acquired of unswitched (488 nm laser, 20 frames/5 s) and
switched (559 nm laser, 20 frames/5 s) dendra-TRPV5 proteins.
All imaging acquisition was performed with CellˆM (Tokyo,
Japan).
Biotinylation of TRPV5—HEK293 cells transiently trans-
fected with TRPV5 in pCINeo/IRES-GFP, TRPV5N358Q in
pCINeo/IRES-GFP, or the empty pCINeo/IRES-GFP vector
(mock) were reseeded on poly-L-lysine-coated (0.1 mg/ml) cul-
ture dishes 1 day after transfection and incubated with sialidase
from V. cholerae (27 mU/ml, Sigma-Aldrich) or recombinant
klotho (2 g/ml, R&D systems) for 16 h at 37 °C. Subsequently,
cells were biotinylated, lysed, and the biotinylated proteins
were precipitated from the cell lysate with neutravidin beads
(Pierce, Etten-leur, The Netherlands) as described previously
(7). For the biotinylation after filipin treatment, the same pro-
tocol was used, but the cells were treated with filipin (5 g/ml,
Sigma-Aldrich) for 45 min prior to lysis.
Transferrin Isoelectric Focusing (tIEF)—The IEF assay was
carried out as previously described, with the following differ-
ences (23). Briefly, plasma samples were incubated for 30 min,
with a solution of 6.7 mM ferric citrate and 0.17 M sodium
hydrogen carbonate, in a ratio of 1:1 (plasma to solution), to
saturate the transferrin with iron. The iron-saturated plasma
was treated with 2 units/ml sialidase (Roche Applied Science,
Mannheim, Germany), 150 g/ml recombinant klotho (R&D
systems) or left untreated for each of the investigated time
points (1, 2, 4, 7 h or overnight). Subsequently, the sampleswere
applied to a hydrated immobiline gel (pH 5–7) on a Phast-
System (GE-Healthcare Life Sciences, Piscataway). Transferrin
isoforms were detected after immunofixation with rabbit anti-
human transferrin antibody (Dako, Glostrup, Denmark) and
Coomassie brilliant blue staining.
COPAS Sorting and PCR—Transgenicmice expressing eGFP
under the control of the TRPV5 promoter have been described
previously (24). Fluorescently labeled DCT/CNT tubules were
isolated from transgenic animals, using aComplexObject Para-
metricAnalyzer and Sorter (COPAS) sorter (UnionBiometrica,
Somerville, MA) as previously described (25, 26). The animal
ethics board of the Radboud University Nijmegen approved all
of the experimental procedures. Tubular, HEK293 and CHO
cell RNA was extracted using TRIzol Total RNA Isolation Re-
agent (Invitrogen BRL, The Netherlands) and processed into
cDNA. The cDNA was mixed with Power SYBR green PCR
Mastermix (Applied Biosystems, Foster City, CA) and exon-
overlapping primers against TRPV5 and galectin-1 and3.
Statistical Analysis—In all experiments, the data are
expressed as mean  S.E. Statistical significance (p  0.05)
was determined by analysis of variance and a Bonferroni
post-hoc test.
RESULTS
Stimulation of TRPV5 Plasma Membrane Retention by
Glycosidases—To study the molecular mechanism of the
klotho-dependent TRPV5 stimulation, we investigated the
effect of various glycosidases on the activity of the channel.
HEK293 cells transiently expressing TRPV5 were treated with
recombinant mouse klotho (2 g/ml), sialidase (27 mU/ml),
-glucuronidase (310 units/ml) or endoglycosidase-F (endoF)
(1 kU/ml) for 16 h and subjected to patch clamp analysis.
HEK293 cells transfected with TRPV5 all showed typical repre-
sentative inwardly-rectifying I/V curves. Fig. 1A represents
cells transiently transfected with TRPV5, untreated or treated
with klotho or endoF. The tested glycosidases significantly
increased the TRPV5-mediated Na current density (Fig. 1B),
while the current density of mock-transfected cells was not
affected (data not shown). The stimulation of TRPV5 channel
activity was confirmed by measuring 45Ca2 uptake in cells
after glycosidase treatment (Fig. 1C). EndoF showed the highest
stimulation of TRPV5 (205  6%), but also -glucuronidase,
sialidase, and klotho increased significantly the TRPV5-depen-
dent Ca2 uptake (166 4%, 147 8%, 155 4%, respectively,
p 0.05).
Subsequently, we investigated the plasma membrane reten-
tion via time-chase analysis. HEK293 cells expressing TRPV5
were treated for 16 h with different glycosidases and subjected
to cell-surface biotinylation. To follow the fate of the biotin-
ylated proteins, the cells were incubated for 0, 1, or 3 h without
glycosidases. In untreated cells, the amount of biotinylated
TRPV5 decreased significantly after 1 and 3 h compared with
the initial time point (0 h) (Fig. 1D, upper panels). For klotho-,
sialidase-, and endoF-treated cells, only a small decrease of
biotinylated TRPV5 channels was detected after 1 and 3 h (Fig.
1D, upper panels). The total expression of TRPV5 was not sig-
nificantly altered by the glycosidase treatment (Fig. 1D, lower
panels).
To further elucidate the mechanism responsible for the
increase in TRPV5 activity after glycosidase treatment, the
N-glycosylation-deficient mutant TRPV5N358Q, was subjected
to time-chase analysis. Compared with wild-type TRPV5 the
plasma membrane abundance of the mutant TRPV5N358Q
TRPV5 Is Regulated Differentially by Klotho and Sialidase
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channel was markedly stable, even after 3 h of incubation
(Fig. 1E).
Glycosidase Treatment Retains TRPV5 at the Plasma Mem-
brane—Traditional time-chase experiments are not able to dis-
tinguish between delayed recycling of proteins from the plasma
membrane or reduced degradation. To overcome this limita-
tion, we established a novel approach by combining live-cell
TIRF-M with a photo-convertible (green to red) fluorescent
protein, Dendra-2, that was fused to the N terminus of the
TRPV5 channel (27). Via this technique an evanescent field at
the glass-cell membrane interface permitted specific detection
and excitation of the channels close to the plasma membrane
(70–100 nm). Proteins in close vicinity to the plasma mem-
branewere photo-switched in TIRFmode using evanescentUV
light (  405 nm). TIRF-M images are shown of the control
and treated conditions for Dendra-2-TRPV5 and Dendra-2-
TRPV5N358Q, captured at the initial time point after photo-
switching and after 30 min (Fig. 2, A and B). The ratio of
fluorescent intensity at an initial time point was calculated by
(Fi Fo)/Fo, where Fo is fluorescent intensity at an initial time
point and Fi fluorescent intensity at a new timepoint. To follow
the presence of the protein at the plasma membrane in time, the
ratio between the switched red fraction (F559) and unswitched
green fraction (F488) was calculated ((F559/F488)/(F559/F488)max).
After treatmentwith sialidase (70 3%) or klotho (75 4%) the
ratio at 30 min was significantly increased compared with
control (47  8%) indicating that TRPV5 is more stable at
the plasma membrane (Fig. 2C). To investigate whether
there is a glycosidase-dependent effect on the N-glycosyla-
tion-deficient mutant, Dendra-2-TRPV5N358Q was subjected
to klotho and sialidase treatment. After glycosidase treatment, no
significant decrease in the fluorescent ratio of Dendra-2-
TRPV5N358Q was found (Fig. 2D).
Klotho and Sialidase Regulate TRPV5 Plasma Membrane
Retention Differently—TIRF-M showed that the cells express-
ing TRPV5N358Q appeared brighter after sialidase treatment,
but not after klotho treatment. The difference between siali-
dase-treated and klotho-treated HEK293 cells expressing
TRPV5N358Q was further investigated. Treatment with klotho
of the cells expressing TRPV5N358Q did not alter the plasma
membrane availability of this mutant as detected by cell surface
biotinylation (104 6%, p 0.2) (Fig. 3, A and B). For the cells
transfected with wild-type TRPV5, the TRPV5 plasma mem-
brane fraction significantly increased after klotho treatment
(140  9%, p  0.05). In contrast, sialidase treatment
enhanced the plasmamembrane fraction of both TRPV5 and
TRPV5N358Q (151  8% and 153  7%, respectively, p 
0.05) (Fig. 3, C and D).
The distinct actions of klotho and sialidasewere further stud-
ied by 45Ca2 uptake assays. In linewith our biochemical obser-
vations, klotho augmented the 45Ca2 influx in HEK293 cells
transfected with TRPV5 (120 2%), but not in cells expressing
TRPV5N358Q (103  5%) (Fig. 3E). In contrast, sialidase
increased TRPV5-mediated 45Ca2 uptake in TRPV5-express-
ing cells(150 11%) as well as in cells expressing TRPV5N358Q
(149  10%) (Fig. 3E). Co-treatment with sialidase and klotho
resulted in an additive increase in TRPV5-mediated Ca2
influx (170 8%). In contrast, no additional 45Ca2 influx was
observed after sialidase and klotho treatment of HEK293 cells
over-expressing TRPV5N358Q (149 10% and 144 9%, siali-
dase versus sialidase and klotho, respectively, p  0.2). The
TRPV5 blocker ruthenium red was applied to determine the
magnitude of the TRPV5-mediated 45Ca2 influx (28).
Disruption of Lipid Rafts Increases TRPV5 Plasma Mem-
braneAbundance—Sialidase is known to affect protein traffick-
ing by interacting with glycolipids in lipid rafts (13). To deter-
mine whether TRPV5 is present in lipid rafts, lipid rafts in
HEK293 cells expressing either TRPV5 or TRPV5N358Q were
disrupted using the cholesterol-chelating drug filipin. After fili-
pin treatment, cell surface biotinylation showed a significant
increase in TRPV5 and TRPV5N358Q abundance at the plasma
membrane (Fig. 4, A–C). Likewise, 45Ca2 uptake assays
FIGURE 1.Different glycosidases increase the TRPV5-mediated Ca2 uptake via plasmamembrane stabilization of the channel. A, I/V relationships of
untreated, klotho- or endoF-treated HEK293 cells expressing TRPV5 are presented. The solid line represents untreated cells, dashed line represents klotho-
treated cells (light gray), and the dotted line represents endoF-treated cells (dark gray). B, TRPV5-mediated Na current in HEK293 cells was measured.
Treatmentwith-glucuronidase, klotho, sialidase, or endoF all resulted in a significantly increased current (n 17–42).C, 45Ca2uptake assays of HEK293 cells
transfected with TRPV5 or the empty vector (mock). These cells were untreated or treated with glycosidase (-glucuronidase, klotho, sialidase, or endoF);
D, time-chase assay of cells transfectedwith TRPV5. Themembrane proteins were biotinylated at 0 h. After 3 h incubationwithout glycosidase, themembrane
fraction of TRPV5was decreased. E, time-chase assay of cells transfected with TRPV5N358Q. All data are presented asmean S.E.; n 3; *, p 0.05, statistically
significant.
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revealed a proportional increase in the functional activity of
TRPV5 (119  3%) and TRPV5N358Q (122  4%), after filipin
treatment versus control (p 0.05) (Fig. 4D). A combination of
filipin and klotho significantly stimulated TRPV5-mediated
45Ca2 uptake (100 6% and 143 10%, control versus filipin
and klotho, respectively p 0.05). No additional 45Ca2 uptake
was observed after combining sialidase with filipin (100  6%
and 113  6%, control versus filipin and sialidase, respectively
p 0.2) (Fig. 4E).
Sialidase and Klotho Modify the N-glycan of Transferrin in a
Different Manner—The difference between klotho and siali-
dase was further confirmed by isoelectric focusing (IEF), using
human blood transferrin as amodel glycoprotein. Via this tech-
nique, proteins are separated based on their isoelectric focus
point. Since sialic acids are negatively charged, a change in the
isoelectric focusing pattern can be detected after sialidase treat-
ment. Plasma transferrin was used asmodel glycoprotein, since
the isoelectric focusing point after removal of the sialic acids
has been characterized. The main isoform of human plasma
transferrin contains two complex biantennary N-glycans, each
terminated by two -2,6-linked sialic acids (23). The protein
was treatedwith klotho (150g/ml) or sialidase (2 units/ml) for
different time intervals. Sialidase treatment resulted in a clear shift
in the IEF pattern of transferrin, indicating the loss of sialic acids
(Fig. 5A). Before treatment, a main isoform with four sialic acids
wasdetectedandafter2hof sialidase treatmentall sialic acidswere
cleaved. Treatment with klotho did not significantly alter the IEF
pattern of transferrin (Fig. 5B).
Galectin-3 Partially Mediates Klotho-dependent TRPV5
Activity—The premise that klotho might not be a specific siali-
dase, would add new mechanistic data to the hypothesis pro-
posed by Cha et al., who suggested that galectin-1 stabilizes
TRPV5 on the plasma membrane after N-glycan modification
by klotho-mediated sialidase activity. InCHOcells they showed
that the stimulatory klotho effect on TRPV5 was absent after
the knock down of galectin-1 (14). However, immunohisto-
chemistry of mouse kidney sections failed to show co-localiza-
tion between TRPV5 and galectin-1 (Fig. 6A). In addition,
galectin-1 was expressed in CHOcells, but not inHEK293 cells,
that were used for this study (Fig. 6B). Since the potential
ligands for galectin-1 and galectin-3 are similar (29), the expres-
sion of galectin-3 in mice sections, HEK293 cells and in Com-
plex Object Parametric Analyzer and Sorter (COPAS)-sorted
distal convoluted and connecting tubules (DCT/CNT) was
checked.Galectin-3 showed a clear co-localizationwithTRPV5
in mice kidney sections. Some tubuli were positive for galec-
tin-3, but not for TRPV5, indicating that galectin-3 activity is
not restricted to TRPV5-expressing tubuli (Fig. 6C). Galectin-3
was also expressed in HEK293 cells, as was shown by RT-PCR
(Fig. 6D). The expression of galectins in the DCT/CNT was
further studied after collecting the nephron segments from
mouse kidney, by theCOPAS large particle flow cytometry (25).
FIGURE 2. Klotho and sialidase stabilize TRPV5 on the plasmamembrane. A and B, TIRF-M images of HEK293 cells expressing Dendra-2-TRPV5 or Dendra-
2-TRPV5N358Q in both red and green channels, after 0 and 30 min. C, ratio of switched red/unswitched green fraction of HEK293 cells expressing Dendra-2-
TRPV5. These cells were subjected to live-cell TIRF-M. At 0min Dendra-2was subjected to UV light ( 405 nm), resulting in a switch from green to red.D, ratio
of switched red/unswitched green fraction of HEK293 cells expressing Dendra-2-TRPV5N358Q. These cells showed no increase in plasma membrane retention
after glycosidase treatment.E, control;, klotho-treated;●, sialidase-treated. All data are expressed as mean S.E.; n 3.
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In isolated DCT/CNT segments only galectin-3 mRNA was
detected by RT-PCR, but not galectin-1 (Fig. 6E). In addition,
also in mouse urine, only galectin-3 was found, which implies
that it has access to the glycan of TRPV5 (Fig. 6F).
The involvement of galectin-3 in the regulation of TRPV5
was further investigated. HEK293 cells, transiently overex-
pressing TRPV5 were treated with 0.67 g/ml recombinant
human galectin-3. 45Ca2 uptake assays revealed an increase in
TRPV5 channel activity after galectin-3 treatment (100  2%
and 131 6%, control versus galectin-3, respectively, p 0.05)
(Fig. 7A), while the activity of the TRPV5N358Q mutant was not
affected by galectin-3 treatment (100 2% and 104 4%, con-
trol versus galectin-3, respectively, p 0.2) (Fig. 7A). Combin-
ing galectin-3 and klotho treatment, or galectin-3 and sialidase
treatment, did not result in additional stimulation of channel
activity (Fig. 7B).
DISCUSSION
Our study demonstrates that glycosidases augment the
plasmamembrane retention of TRPV5, where klotho and siali-
dase increase the TRPV5 plasma membrane fraction via dis-
tinct mechanisms. The effect of sialidase, in contrast to klotho,
is independent of the glycosylation status of TRPV5.Moreover,
galectin-3 is a potential mediator for klotho-dependent TRPV5
stabilization.Our conclusions are based on the following obser-
vations: (i) biochemical assays showed that klotho, sialidase,
-glucuronidase and endoF increase the TRPV5 channel activ-
ity andmembrane retention; (ii) the plasmamembrane stability
of TRPV5N358Q was altered by sialidase, but not by klotho; (iii)
IEF demonstrated no modification of the N-glycan sialic acids
after klotho treatment, in transferrin; (iv) only galectin-3, but
not galectin-1, co-localizes with TRPV5 in DCT/CNT of the
FIGURE3.TRPV5stabilizationviaklotho isN-glycan-dependent.A, biotin-
ylation of HEK293 cells expressing TRPV5 or TRPV5N358Q after klotho treat-
ment, a representative blot is depicted; B, relative TRPV5 cell surface expres-
sion with or without klotho treatment (white and black bar, respectively); C,
biotinylation of HEK293 cells expressing TRPV5 or TRPV5N358Q after sialidase
treatment, a representative blot is depicted; D, relative TRPV5 cell surface
expression with or without sialidase treatment (white and black bar, respec-
tively); E, 45Ca2 uptake assay of cells transfected with TRPV5 or TRPV5N358Q
after treatment with klotho, sialidase, a combination of these glycosidases,
ruthenium red or left untreated. All data are presented asmean S.E.; n 3;
*, p 0.05, statistically significant.
FIGURE 4. TPRV5 plasmamembrane retention is regulated via lipid rafts.
A, biotinylation of HEK293 cells expressing TRPV5 after filipin treatment, a
representativeblot is depicted.B, biotinylationof cells expressingTRPV5N358Q
after filipin treatment, a representative blot is depicted. C, relative cell surface
expression, with or without filipin treatment (white and black bar, respec-
tively) of TRPV5 (n 6) or TRPV5N358Q (n 3) overexpressing cells; D, 45Ca2
uptake assay in the presence of filipin (n  3). Filipin significantly increases
Ca2 uptake independent on the N-glycan of TRPV5 (white bar). E, 45Ca2
uptake assay in the presence of filipin and klotho or sialidase (n 3). Klotho
significantly increased TRPV5-dependent 45Ca2-uptake in the presence of
flilipin, while sialidase treatment gave no additional effect. All data are pre-
sented as mean S.E.; *, p 0.05, statistically significant.
FIGURE 5. The isoelectric focusing pattern of transferrin is not modified
by klotho. A, tIEF after sialidase treatment. Hydrolysis of sialic acids by siali-
dase treatment results in a shift of the IEF pattern. B, isoelectric focusing of
transferrin after klotho treatment. Klotho has no influence on the amount of
sialic acids.
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kidney; (v) galectin-3 increased the TRPV5-mediated Ca2
influx in a N-glycan-dependent manner.
It was demonstrated that glycosidase treatment increases the
TRPV5 channel activity. This effect was detected by treatment
with different types of glycosidase (endoF, sialidase, and -glu-
curonidase). TRPV5 channel activity was measured via time-
chase experiments in combination with functional analyses (7,
14). A general mechanism or pathway for all the applied glyco-
sidases remains unknown, since their enzymatic effects are dis-
tinct: endoF cleaves the entire N-glycan (30), sialidase hydro-
lyzes end-standing sialic acids, while -glucuronidase cleaves
glucuronic acids (31). One hypothesis is that any modification
of theN-glycan improves the plasmamembrane stabilization of
TRPV5. Alternatively, since all glycans on the plasma mem-
brane were hydrolyzed, the detected stabilizing effect could be
independent of the N-glycan of TRPV5. This would mean that
the plasma membrane stabilization is due to an indirect effect
on TRPV5. However, the stimulatory effect of klotho is depen-
dent on the N-glycan of TRPV5.
Plasmamembrane retention canoccur via twodistinct routes; a
delayed retrieval from theplasmamembrane and subsequent deg-
radation of the channel, or via an accelerated/increased insertion
at the plasmamembrane. It is difficult to distinguish betweenboth
routes based on time-chase experiments. To pinpoint the fate of
glycosidase-treated TRPV5, we developed a novel assay, com-
bining the live-cell imaging technique, TIRF-M, with photoac-
tivatable fluorophores. Important advantages of TIRF-M over
confocal microscopy are the higher Z resolution, high signal to
noise ratio, increased contrast in fluorescence and reduced
bleaching. The ease in combining kinetic studies with local
information in living samples results in fast data acquisition
(32). We showed that TRPV5 has a reduced mobile fraction
FIGURE 6. Galectin-3 is a candidate mediator of the klotho effect on TRPV5. A, immunohistochemistry on DCT/CNT for TRPV5 and galectin-1 shows no
co-localization. B, immunoblot of CHO cell lysate demonstrated that galectin-1 was present. After RT-PCR on the cDNA of HEK293 cells, no galectin-1 was
detected. C, immunohistochemistry onDCT/CNT for TRPV5 and galectin-3 demonstrate a co-localization;D, immunoblot of CHO cell lysate demonstrated that
galectin-3 was expressed. After RT-PCR on the cDNA of HEK293 cells, galectin-3 was detected. E, cDNA of the DCT/CNT cells was analyzed by RT-PCR and only
galectin-3 was detected. F, total kidney lysate of mouse contains both galectin-1 and galectin-3, while mouse urine only contains galectin-3.
FIGURE 7.TRPV5 channel activity is regulatedby extracellular galectin-3.
A, 45Ca2-uptake assay in cells overexpressing TRPV5 (n  5) or TRPV5N358Q
(n 3) in the presence and absence of human galectin-3. Galectin-3 signifi-
cantly increased wild type TRPV5 (white bar) but not TRPV5N358Q channel
activity (white bar). All data arepresentedasmeanS.E.; *,p0.05, statistically
significant. B, 45Ca2-uptake assay of cells overexpressing TRPV5 treated with
klotho, sialidase, galectin-3, or a combination of these enzymes. No additional
stimulationwasdetected after treatmentwith klotho andgalectin-3. All data are
presented asmean S.E.; n 5; *, p 0.05, statistically significant.
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after sialidase or klotho treatment, indicating that these glyco-
sidases enable TRPV5 to reside longer on the plasma mem-
brane. Our control, TRPV5N358Q lacks N-glycosylation and is
devoid of any glycosylation-dependent regulation. This mutant
demonstrated no decrease in the mobile fraction after glycosi-
dase treatment. Overall this mutant had a smaller mobile frac-
tion compared with TRPV5.
While conducting the TIRF-M based live-cell imaging it was
observed that after sialidase treatment, the cells expressing
TRPV5N358Q appeared brighter. This effect was not detected
after klotho treatment. This prompted us to investigate the
effect of sialidase on TRPV5N358Q. An increased plasma mem-
brane abundance of TRPV5N358Q was detected via biotinyla-
tion, after sialidase treatment. It was noticed that biotinylated
TRPV5 often runs as a smear band on SDS-PAGE. The reason
for this effect remains unclear, however, it could indicate that
plasma membrane TRPV5 is more heterogeneous compared
with intracellular TRPV5.
The effect of sialidase treatment on the TRPV5N358Qmutant
was confirmed using 45Ca2 uptake experiments. TRPV5-me-
diated 45Ca2 uptake was increased after treatment with both
sialidase and klotho in an additive manner, indicating that
klotho and sialidase act via different pathways. Interestingly,
Cha et al. postulated that sialidase did not increase the plasma
membrane abundance of TRPV5N358Q (14). However, in their
study CHO cells were used as a model system, while in the
present study HEK293 cells were employed.
We proved that filipin, an inhibitor of microdomain clustering,
increases the cell surface expression of TRPV5/TRPV5N358Q and
45Ca2 uptake through TRPV5 and TRPV5N358Q. This finding
indicated that TRPV5 and TRPV5N358Q channels are present and
internalized in clustered microdomains. Recently, it has been
suggested that sialidase prevents microdomain clustering and
lipid raft formation by hydrolyzing sialic acids from glycosph-
ingolipids (13). Microdomain clustering is known to stimulate
caveolae-mediated endocytosis and since sialidase treatment
inhibits this microdomain clustering, the endocytosis is
reduced (13). Because TRPV5 is present in these microdo-
mains, the channel ismost likely stabilized on the plasmamem-
brane by sialidase via reduced lipid raft formation and thereby a
decreased caveolae-mediated endocytosis. In agreement with
this hypothesis, sialidase treatment did not result in additional
stimulation of 45Ca2 uptake after disrupting the lipid rafts by
filipin. This finding, together with the sialidase-mediated stim-
ulation of Ca2 uptake via TRPV5N358Q, and increased wild
typeTRPV5 activation after klotho treatment in the presence of
filipin, suggested that klotho and sialidase act via two different
pathways to modulate channel activity. Sialidase, in contrast to
klotho, stimulates TRPV5 via a mechanism that is independent
of the N-glycan of TRPV5.
To further confirm this hypothesis IEF was employed using
the well-characterized transferrin as a model protein. Sialidase
altered the IEF pattern of transferrin, a substrate exposing ter-
minal sialic acids, including 2,6-linked sialic acids (33, 34).
Klotho treatment did not result in anymodification, suggesting
a lack of sialidase activity of klotho. Alternatively, it is possible
that sialidase activity of klotho is tightly structure-related,
cleaving only one sialic acid that is presented in a specific sugar
signature, which may be absent in transferrin. The difference
between sialidase and klotho prompted us to investigate the
following step in the proposedmechanism. Cha et al. suggested
that galectin-1 is a key player in the regulation of TRPV5. Inter-
estingly, immunohistochemistry on renal mouse cortex sec-
tions showed no co-localization of galectin-1 with TRPV5.
Galectin-1 is not expressed inHEK293 cells and therefore the in
vitro measured effect of klotho is likely to be galectin-1 inde-
pendent. Since the potential ligands for galectin-1 and galec-
tin-3 are highly similar, we investigated the role of galectin-3 in
this process. Galectin-3 is a carbohydrate-binding protein that is
highly abundant in type A intercalated cells of the cortical collect-
ing duct and the distal tubules (35, 36). An important difference
between galectin-1 and galectin-3 is that the dimer galectin-1
requires a terminal galactose for binding, while the oligomer
galectin-3 binds to repeating [-3Gal--(1–4)-GlcNAc--1-]n
or poly-N-acetyllactosamine sequences that not necessarily
contain a terminal -galactoside residue (37). Galectin-3 co-lo-
calized with TRPV5, although the presence of galectin-3 is not
restricted to TRPV5-expressing tubuli. In addition, COPAS
sorted DCT/CNT cells were enriched with galectin-3 mRNA,
while galectin-1mRNAwas not detected, indicating that galec-
tin-3 may be involved in TRPV5 regulation. In contrast to the
TRPV5N358Q mutant, wild type TRPV5 channel activity was
increased upon treatment with galectin-3. This suggests that
galectin-3-mediated channel activity is dependent on the
N-glycan of TRPV5. Interestingly, co-treatmentwith galectin-3
and klotho did not additively stimulate TRPV5 activity implying
that klotho and galectin-3 stimulate TRPV5 activity in a similar
manner. An interesting observation, as detected with TIRF-M,
biotinylation, 45Ca2 uptake experiments and electrophysiology
was the stable expression of TRPV5N358Q mutant on the plasma
membrane without any treatment. It was proposed that galectin
stabilizes TRPV5 on the plasma membrane. However, due to the
absence of an N-glycan on the TRPV5N358Q mutant, it is striking
that this mutant retains on the plasma membrane. Since the
TRPV5N358Q mutant was transiently overexpressed, one could
hypothesize that some glycosylation-deficient channels are forced
to the plasma membrane. Since the entireN-glycan is absent, the
protein cannot be appropriately regulated by the cell and will
remainmore stable on the plasmamembrane.
Likewise, Kohno et al. demonstrated a significant difference
between the internalization rates of the wild type endothelial
differentiation gene-1 product (Edg-1, a G-coupled receptor)
and the nonglycosylated N30D-Edg-1 mutant (39). The wild
type G-coupled receptor was internalized at higher rates com-
paredwith the nonglycosylatedN30D-Edg-1 receptor. Another
explanation could be that the channel is destabilized due to
steric hindrance in the presence of the N-glycan, resulting in a
reduced amount of TRPV5 on the cell surface. Consequently,
any reduction of theN-glycan ofTRPV5 results in an increase of
plasma membrane stability and, therefore, channel activity.
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